0001493152-21-021753.txt : 20210901 0001493152-21-021753.hdr.sgml : 20210901 20210901123323 ACCESSION NUMBER: 0001493152-21-021753 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210901 DATE AS OF CHANGE: 20210901 EFFECTIVENESS DATE: 20210901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Voltron Therapeutics, Inc. CENTRAL INDEX KEY: 0001835742 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-411975 FILM NUMBER: 211229399 BUSINESS ADDRESS: STREET 1: 575 FIFTH AVE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 953-4936 MAIL ADDRESS: STREET 1: 575 FIFTH AVE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 D 1 primary_doc.xml X0708 D LIVE 0001835742 Voltron Therapeutics, Inc. 12 E 49TH STREET 11TH FLOOR NEW YORK NY NEW YORK 10017 646-335-5923 DELAWARE None None Corporation true 2017 Patrick Gallagher 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Executive Officer Director Chief Executive Officer Matthew Duffy 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Executive Officer Director President James Ahern 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Paul Korner 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Anthony Zook 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Matthew Eitner 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Biotechnology Decline to Disclose 06b false 2021-08-19 false true true false 0 Laidlaw & Company (UK) Ltd. 119037 None None 521 FIFTH AVENUE, 12TH FLOOR NEW YORK NY NEW YORK 10175 All States true 12000000 2502011 9497989 false 36 250201 true 0 0 false Voltron Therapeutics, Inc. /s/ Matthew Duffy Matthew Duffy President 2021-08-31